Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes

Brain

Volumn 120, Issue 12, 1997, Pages 2207-2217

  Backman L ^a,b,c   Robins Wahlin, T B ^b   Lundin, A ^b   Ginovart, N ^b   Farde, L ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c STOCKHOLM GERONTOLOGY RESEARCH CENTER   (Sweden)

Author keywords

Cognition; Dopaminergic markers; Huntington's disease; MRI; PET

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR;

ADULT; ARTICLE; BRAIN SIZE; BRAIN TOMOGRAPHY; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; HUNTINGTON CHOREA; MALE; MEMORY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; BIOLOGICAL MARKERS; BRAIN; CARBON RADIOISOTOPES; CARRIER PROTEINS; COCAINE; COGNITION DISORDERS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; HUNTINGTON DISEASE; MAGNETIC RESONANCE IMAGING; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MEMORY; MIDDLE AGED; NERVE TISSUE PROTEINS; ORGAN SPECIFICITY; PERCEPTION; PREDICTIVE VALUE OF TESTS; RACLOPRIDE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; REFERENCE VALUES; SALICYLAMIDES; SPEECH; THINKING; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 2642666489     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/120.12.2207     Document Type: Article

References (100)

1. Alexander GE, DeLong MR, Strick PL, Parallel organization of functionally segregated circuits linking basal ganglia and cortex. [Review]. Annu Rev Neurosci 1986; 9: 357-81.
2. Almkvist O, Wahlund LO, Andersson-Lundman G, Basun H, Bäckman L. White-matter hyperintensity and neuropsychological functions in dementia and healthy aging. Arch Neurol 1992; 49: 626-32.
3. Andreasen NC, Flaum M, Swayze V 2d, O'Leary DS, Alliger R, Cohen G, et al. Intelligence and brain structure in normal individuals [see comments]. Am J Psychiatry 1993; 150: 130-4. Comment in: Am J Psychiatry 1994; 151: 456-7.
4. Andreasen NC, Flaum M, Swayze V 2d, O'Leary DS, Alliger R, Cohen G, et al. Intelligence and brain structure in normal individuals [see comments]. Am J Psychiatry 1993; 150: 130-4. Comment in: Am J Psychiatry 1994; 151: 456-7.
5. Bamford KA, Caine ED, Kido DK, Plassche WM, Shoulson I, Clinical-pathologic correlation in Huntington's disease: a neuropsychological and computed tomography study. Neurology 1989; 39: 796-801.
6. Benton AL, Hamsher K de S. Multilingual aphasia examination. Iowa City, Iowa: AJA Associates, 1989.
7. Berg EA. A simple objective test for measuring flexibility in thinking. J Gen Psychol 1948; 39: 15-22.
8. Bergström M. Boethius J, Eriksson L, Greitz T, Ribbe T, Widen L. Head fixation device for reproducible position alignment in transmission CT and positron emission tomography. J Comput Assist Tomogr 1981; 5: 136-41.
9. Björklund A, Lindvall O. Dopamine-containing systems in the CNS. In: Björklund A, Hökfelt T, editors. Handbook of chemical neuroanatomy, Vol. 2: classical transmitters in the CNS. Part 1. Amsterdam: Elsevier, 1984: 55-122.
10. Boll TJ, Heaton R, Reitan RM. Neuropsychological and emotional correlates of Huntington's chorea. J Nerv Ment Dis 1974; 158: 61-9.
11. Brandt J, Butters N, The neuropsychology of Huntington's disease. Trends Neurosci 1986; 9: 118-20.
12. Brandt J, Bylsma FW, Aylward EH, Rothlind J, Gow CA. Impaired source memory in Huntington's disease and its relation to basal ganglia atrophy. J Clin Exp Neuropsychol 1995; 17: 868-77.
13. Brouwers P, Cox C, Martin A, Chase T, Fedio P. Differential perceptual-spatial impairment in Huntington's and Alzheimer's dementias. Arch Neurol 1984; 41: 1073-6.
14. Brown RG, Marsden CD. 'Subcortical dementia': the neuropsychological evidence. [Review]. Neuroscience 1988; 25: 363-87.
15. Bruyn GW, Dots GT, Dom R. Huntington's chorea: current neuropathological status. In: Chase TN, Wexsler NS, Barbeau A, editors. Huntington's disease. New York: Raven Press, 1979: 83-93.
16. Butters N, Sax D, Montgomery K, Tarlow S. Comparison of the neuropsychological deficits associated with early and advanced Huntington's disease. Arch Neurol 1978; 35: 585-9.
17. Butters N, Wolfe J, Martone M, Granholm E, Cermak LS, Memory disorders associated with Huntington's disease: verbal recall, verbal recognition and procedural memory. Neuropsychologia 1985; 23: 729-43.
18. Caine ED, Ebert MH, Weingartner H. An outline for the analysis of dementia: the memory disorder of Huntington's disease. Neurology 1977; 27: 1087-92.
19. 2 sites in Parkinson syndrome of different etiology. Brain Res 1989; 483: 30-8.
20. Crosson BA. Subcortical functions in language and memory. New York: Guilford, 1992.
21. Cummings JL. Subcortical dementia: neuropsychology, neuropsychiatry, and pathophysiology. [Review]. Br J Psychiatry 1986; 149: 682-97.
22. Dom R, Malfroid M, Baro F. Neuropathology of Huntington's chorea: studies of the ventrobasal complex of the thalamus. Neurology 1976; 26: 64-8.
23. 2 dopamine receptor binding in the living human brain by PET. Science 1986; 231: 258-61.
24. 11C raclopride. Psychopharmacology (Berl) 1987; 92: 278-84.
25. 11C)b-CIT binding to monoamine transporters in the monkey and human brain. Synapse 1994; 16: 93-103.
26. 11C]raclopride in man. Synapse 1995; 20: 200-8.
27. Fedio P, Cox CS, Neophytides A, Canal-Frederick G, Chase TN. Neuropsychological profile of Huntington's disease: patients and those at risk. In: Chase TN, Wexsler NS, Barbeau A, editors. Huntington's disease. New York: Raven Press, 1979: 239-55.
28. Ferrante RJ, Kowall NW. Tyrosine hydroxylase-like immunoreactivity is distributed in the matrix compartment of normal human and Huntington's disease striatum. Brain Res 1987; 416: 141-6.
29. 3H) forskolin binding. Exp Neurol 1990; 110: 219-27.
30. Filoteo JV, Delis DC, Roman MJ, Demadura T, Ford E, Butters N, et al. Visual attention and perception in patients with Huntington's disease: comparisons with other subcortical and cortical dementias. J Clin Exp Neuropsychol 1995; 17: 654-67.
31. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
32. Gerfen CR. The neostriatal mosaic: striatal patch-matrix organization is related to cortical lamination. Science 1989; 246: 385-8.
33. Ginovart N, Lundin A, Farde L, Halldin C, Backman L, Swahn CG, et al. PET study of'pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease. Brain 1997; 120: 501-14.
34. Giros B, el Mestikawy S, Godinot N, Zheng K, Han H, Yang-Feng T, et al. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol Pharmacol 1992; 42: 383-90.
35. Goto S, Hirono A, Rojas-Corona RR. An immunohistochemical investigation of the human neostriatum in Huntington's disease. Ann Neurol 1989; 25: 298-304.
36. Grant DA, Berg EA. A behavioral analysis of degree of reinforcement and ease of shifting to new responses in a Weigltype card-sorting problem. J Exp Psychol 1948; 38: 404-11.
37. Graveland GA, Williams RS, DiFiglia M. Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. Science 1985; 227: 770-3.
38. Graybiel A, Ragsdale CW Jr. Fiber connections of the basal ganglia. In: Cuenod M, Kreutzberg GW, Bloom FE, editors. Development and chemical specificity of neurons. Progress in brain research, Vol. 51. Amsterdam: North-Holland, 1979: 239-83.
39. 11C-N-methyl-spiperone. Acta Neurol Scand 1987; 75: 87-94.
40. 3H raclopride. J Neural Transm 1988; 73: 7-21.
41. 2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology 1994; 11: 245-56.
42. Halstead WC. Brain and intelligence. Chicago: University of Chicago Press, 1947.
43. Harris GJ, Aylward EH, Peyser CE, Pearlson GD, Brandt J, Roberts-Twillie JV, et al. Single photon emission computed tomographic blood flow and magnetic resonance volume imaging of basal ganglia in Huntington's disease. Arch Neurol 1996; 53: 316-24.
44. Incisa della Rocchetta A, Milner B. Strategic search and retrieval inhibition: the role of the frontal lobes. Neuropsychologia 1993; 31: 503-24.
45. Janowsky JS, Shimamura AP, Kritchevsky M, Squire LR. Cognitive impairment following frontal lobe damage and its relevance to human amnesia. Behav Neurosci 1989; 103: 548-60.
46. Jayaraman A. Thalamostriate projections - an overview. In: McKenzie JS, Klemm RE, Wilcock LN, editors. The basal ganglia. Advances in behavioral biology, Vol. 27. New York: Plenum Press, 1984: 69-86.
47. Jernigan TL, Salmon DP, Butters N, Hesselink JR. Cerebral structure on MRI. Part II: specific changes in Alzheimer's and Huntington's diseases. Biol Psychiatry 1991; 29: 68-81.
48. Josiassen RC, Curry LM, Mancall EL. Development of neuropsychological deficits in Huntington's disease. Arch Neurol 1983; 40: 791-6.
49. Kuhar MJ, Sanchez-Roa P, Wong DF, Dannals RF, Grigoriadis DE, Lew R, et al. Dopamine transporter: biochemistry, pharmacology and imaging. [Review]. Eur Neurol 1990; 30 Suppl 1: 15-20.
50. Lange KW, Sahakian BJ, Quinn NP, Marsden CD, Robbins TW. Comparison of executive and visuospatial memory function in Huntington's disease and dementia of Alzheimer type matched for degree of dementia. J Neurol Neurosurg Psychiatry 1995; 58: 598-606.
51. Lawrence AD, Sahakian BJ, Hodges JR, Rosser AE, Lange KW, Robbins TW. Executive and mnemonic functions in early Huntington's disease. Brain 1996; 119: 1633-45.
52. Lezak MD. Neuropsychological assessment. 3rd ed. New York: Oxford University Press, 1995.
53. Marione M, Butters N, Payne M, Becker JT, Sax DS. Dissociations between skill learning and verbal recognition in amnesia and dementia. Arch Neurol 1984; 41: 965-70.
54. Mayeux R, Stern Y, Rosen J, Benson F. Is 'subcortical dementia' a recognizable clinical entity? Ann Neurol 1983; 14: 278-83.
55. Milner B. Effects of different brain lesions on card sorting. Arch Neurol 1963; 9: 90-100.
56. Mohr E, Brouwers P, Claus JJ, Mann UM, Fedio P, Chase TN. Visuospatial cognition in Huntington's disease. Mov Disord 1991; 6: 127-32.
57. Molander B. Imagery, visual and tactual dimensions of imagery, and meaningfulness: Swedish norms for 858 nouns. (Umeå Psychological Reports No. 178). Umeå (Sweden): University of Umeå, Department of Psychology, 1984.
58. Moscovitch M. Multiple dissociations of function in amnesia. In: Cermak LS, editor. Human memory and amnesia. Hillsdale (NJ): Lawrence Erlbaum, 1982: 337-70.
59. Moses JA Jr, Golden CJ, Berger PA, Wisniewski AM. Neuropsychological deficits in early, middle, and late stage Huntington's disease as measured by the Luria-Nebraska Neuropsychological Battery. Int J Neurosci 1981; 14: 95-100.
60. 125I) epidepride. Eur J Pharmacol 1992; 227: 443-5.
61. Nagahama Y, Fukuyama H, Yamauchi H, Matsuzaki S, Konishi J, Shibasaki H, et al. Cerebral activation during performance of a card sorting test. Brain 1996; 119: 1667-75.
62. Osterrieth PA. Le test de copie d'une figure complexe. Arch Psychol 1944; 30: 206-356.
63. Parent A. Extrinsic connections of the basal ganglia. [Review]. Trends Neurosci 1990; 13: 254-8.
64. Parent A, Hazrati LN. Functional anatomy of the basal ganglia. I. The cortico-basal-ganglia-thalamo-cortical loop. [Review]. Brain Res Brain Res Rev 1995; 20: 91-127.
65. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data: generalizations. J Cereb Blood Flow Metab 1985; 5: 584-90.
66. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983; 3: 1-7.
67. Reiner A, Albin RL, Anderson KD, D'Amato CJ, Penney JB, Young AB. Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci USA 1988; 85: 5733-7.
68. Reitan RM. Manual for administration of neuropsychological test batteries for adults and children. Tucson (AZ): Reitan Neuropsychological Laboratory, 1979.
69. Reitan RM, Davison LA. Clinical neuropsychology: current status and applications. Washington (DC): V. H. Winston, 1974.
70. Rey A. L'examen psychologique dans les cas d'encéphalopathie traumatique. Arch Psychol 1941; 28: 286-340.
71. Richfield EK, O'Brien CF, Eskin T, Shoulson I. Heterogeneous dopamine receptor changes in early and late Huntington's disease. Neurosci Lett 1991; 132: 121-6.
72. Robbins TW, James M, Owen AM, Lange KW, Lees AJ, Leigh PN, et al. Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction. J Neurol Neurosurg Psychiatry 1994; 57: 79-88.
73. Rosser AE, Hodges JR. Initial letter and semantic category fluency in Alzheimer's disease, Huntington's disease, and progressive supranuclear palsy [see comments], J Neurol Neurosurg Psychiatry 1994; 57: 1389-94. Comment in: J Neurol Neurosurg Psychiatry 1995; 58: 520-1.
74. Rosser AE, Hodges JR. Initial letter and semantic category fluency in Alzheimer's disease, Huntington's disease, and progressive supranuclear palsy [see comments], J Neurol Neurosurg Psychiatry 1994; 57: 1389-94. Comment in: J Neurol Neurosurg Psychiatry 1995; 58: 520-1.
75. Rugg MD, Fletcher PC, Frith CD, Frackowiak RS, Dolan RJ. Differential activation of the prefrontal cortex in successful and unsuccessful memory retrieval. Brain 1996; 119: 2073-83.
76. Sax DS, O'Donnell B, Butters N, Menzer L, Montgomery K, Kayne HL. Computed tomographic, neurologic, and neuropsychological correlates of Huntington's disease. Int J Neurosci 1983; 18: 21-36.
77. Schacter DL. Memory, amnesia, and frontal lobe dysfunction. Psychobiology 1987; 15: 21-36.
78. 1 receptor number - a sensitive PET marker for early brain degeneration in Huntington's disease. Eur Arch Psychiatry Clin Neurosci 1994; 243: 249-55.
79. 4 receptors in Parkinson's, schizophrenia, and control brain striata. Synapse 1993; 14: 247-53.
80. Segalowitz SJ, Unsal A, Dywan J. CNV evidence for the distinctiveness of frontal and posterior neural processes in a traumatic brain-injured population. J Clin Exp Neuropsychol 1992; 14: 545-65.
81. Shallice T, Fletcher P, Frith CD, Grasby P, Frackowiak RS, Dolan RJ. Brain regions associated with acquisition and retrieval of verbal episodic memory. Nature 1994; 368: 633-5.
82. Shoulson I, Plassche W, Odoroff C. Huntington disease: caudate atrophy parallels functional impairment [abstract]. Neurology 1982; 32 Suppl: A143.
83. Squire LR, Ojemann JG, Miezin FM, Petersen SE, Videen TO, Raichle ME. Activation of the hippocampus in normal humans: a functional anatomical study of memory. Proc Natl Acad Sci USA 1992; 89: 1837-41.
84. Starkstein SE, Brandt J, Holstein S, Strauss M, Berthier ML, Pearlson GD, et al. Neuropsychological and neuroradiological correlates in Huntington's disease. J Neurol Neurosurg Psychiatry 1988; 51: 1259-63.
85. Starkstein SE, Brandt J, Bylsma F, Peyser C, Folstein M, Folstein SE. Neuropsychological correlates of brain atrophy in Huntington's disease: a magnetic resonance imaging study. Neuroradiology 1992; 34: 487-9.
86. Taylor EM. Psychological appraisal of children with cerebral deficits. Cambridge (MA): Harvard University Press, 1959.
87. Taylor HG, Hansotia P. Neuropsychological testing of Huntington's patients: clues to progression. J Nerv Ment Dis 1983; 171: 492-6.
88. Tranel D, Anderson SW, Benton A. Development of the concept of 'executive function' and its relationship to the frontal lobes. In: Boiler F, Grafman J, editors. Handbook of neuropsychology, Vol. 9. Amsterdam: North-Holland, 1994; 125-48.
89. Tröster AI, Salmon DP, McCullough D, Butters N. A comparison of the category fluency deficits associated with Alzheimer's and Huntington's disease. Brain Lang 1989; 37: 500-13.
90. Tulving E, Kapur S, Craik FI, Moscovitch M, Houle S. Hemispheric encoding/retrieval asymmetry in episodic memory: Positron emission tomography findings [see comments]. [Review]. Proc Natl Acad Sci USA 1994; 91: 2016-20. Comment in: Proc Natl Acad Sci USA 1994; 91: 1989-91.
91. Tulving E, Kapur S, Craik FI, Moscovitch M, Houle S. Hemispheric encoding/retrieval asymmetry in episodic memory: Positron emission tomography findings [see comments]. [Review]. Proc Natl Acad Sci USA 1994; 91: 2016-20. Comment in: Proc Natl Acad Sci USA 1994; 91: 1989-91.
92. 2 receptor binding in patients with Huntington's disease and other choreas. Brain 1995; 118: 689-96.
93. Ungerstedt U. Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol Scand 1971; Suppl 367: 1-48.
94. Webb M, Trzepacz PT. Huntington's disease: correlations of mental status with chorea. Biol Psychiatry 1987; 22: 751-61.
95. Wechsler D. Manual for the Wechsler Adult Intelligence Scale-Revised. New York: Psychological Corporation, 1981.
96. Weinberger DR, Berman KF, Zee RF. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia [see comments]. Arch Gener Psychiatry 1986; 43: 111-24. Comment in: Arch Gener Psychiatry 1991; 48: 282-3.
97. Weinberger DR, Berman KF, Zee RF. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia [see comments]. Arch Gener Psychiatry 1986; 43: 111-24. Comment in: Arch Gener Psychiatry 1991; 48: 282-3.
98. Wexler NS. Perceptual-motor, cognitive, and emotional characteristics of persons at risk for Huntington's disease. In: Chase TN, Wexler NS, Barbeau A, editors. Huntington's disease. New York: Raven Press, 1979: 257-71.
99. Wheeler MA, Stuss DT, Tulving E. Frontal lobe damage produces episodic memory impairment. J Int Neuropsychol Soc 1995; 1: 525-36.
100. Wienhard K, Dahlbom M, Eriksson L, Michel C, Bruckbauer T, Pietrzyk U, et al. The ECAT EXACT HR: Performance of a new high resolution positron scanner. J Comput Assist Tomogr 1994; 18: 110-8.